Details of the Drug

General Information of Drug (ID: DME2W98)

Drug Name
SGX301
Indication
Disease Entry ICD 11 Status REF
Cutaneous T-cell lymphoma 2B01 Phase 3 [1]
Cross-matching ID
PubChem CID
3663
TTD ID
D0NC9E

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)